Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2022-01-26 00:00:00 ET · period of report 2022-01-26 · accession 0001209191-22-005107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-26 | 2022-01-26 | CCCC | Anderson Kenneth Carl | Dir | M - OptEx | $3.90 | +2,137 | 88.0K | +2% | +$8,338 |
| DM | 2022-01-26 | 2022-01-26 | CCCC | Anderson Kenneth Carl | Dir | M - OptEx | $0.00 | -2,137 | 2,668 | -44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-26 | M | A | 803 | $2.11 | 86,641 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-26 | M | A | 1,334 | $4.98 | 87,975 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-01-26 | M | D | 803 | $0.00 | 2,137 | D | $2.11 · — to 2026-07-12 | 803 Common Stock | (F5) 12.5% of the shares underlying this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-01-26 | M | D | 1,334 | $0.00 | 2,668 | D | $4.98 · — to 2030-07-02 | 1,334 Common Stock | (F6) The shares underlying this option vest and become exercisable in 12 equal quarterly installments, with the first installment vested on October 1, 2020. |